BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10928078)

  • 1. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
    Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model.
    Katano K; Tsujitani S; Saito H; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 1997; 17(6D):4547-52. PubMed ID: 9494566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer.
    Katano K; Tsujitani S; Maeta M; Fukuda K; Oka S; Hisamitsu K; Ikeguchi M; Kaibara N
    Oncol Rep; 2001; 8(3):605-9. PubMed ID: 11295088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.
    Tsujitani S; Oka A; Kondo A; Katano K; Oka S; Saito H; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Jul; 57(1):77-82. PubMed ID: 10394129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
    Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
    Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
    Kondo A; Maeta M; Oka A; Tsujitani S; Ikeguchi M; Kaibara N
    Br J Cancer; 1996 May; 73(10):1166-70. PubMed ID: 8630273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
    Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
    Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer.
    Tsujitani S; Fukuda K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Surgery; 2002 Jan; 131(1 Suppl):S98-104. PubMed ID: 11821794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
    Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
    Isambert N; Correia M; Cercueil JP; Zanetta S; Osmak L; Flesch M; Krause D; Coudert B; Fargeot P; Bedenne L; Chauffert B
    J Exp Clin Cancer Res; 2001 Jun; 20(2):183-8. PubMed ID: 11484972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
    Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
    Panteix G; Beaujard A; Garbit F; Chaduiron-Faye C; Guillaumont M; Gilly F; Baltassat P; Bressolle F
    Anticancer Res; 2002; 22(2B):1329-36. PubMed ID: 12168946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study on paratumoral injection of cisplatin-loaded microspheres for gastric cancer.
    Narita K; Ikuta H; Hamabe Y; Kuroda Y
    Kobe J Med Sci; 1999 Oct; 45(5):229-43. PubMed ID: 10853189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
    Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
    Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
    Zeamari S; Floot B; van der Vange N; Stewart FA
    Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The inhibitory effect of intraperitoneal hyperthermic and hypotonic chemotherapy on ascites cancer cells in mice].
    Chen Z; Peng D; Tan J
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):101-4. PubMed ID: 7657323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
    Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
    Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
    Los G; Mutsaers PH; Ruevekamp M; McVie JG
    Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.